NO20081045L - Forbindelser og fremgangsmater for behandling av cancer - Google Patents

Forbindelser og fremgangsmater for behandling av cancer

Info

Publication number
NO20081045L
NO20081045L NO20081045A NO20081045A NO20081045L NO 20081045 L NO20081045 L NO 20081045L NO 20081045 A NO20081045 A NO 20081045A NO 20081045 A NO20081045 A NO 20081045A NO 20081045 L NO20081045 L NO 20081045L
Authority
NO
Norway
Prior art keywords
compounds
methods
treating cancer
leukemia
potent
Prior art date
Application number
NO20081045A
Other languages
English (en)
Inventor
Paul Gutsch
Brian Renzelmann
Original Assignee
Ziopharm Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ziopharm Oncology Inc filed Critical Ziopharm Oncology Inc
Publication of NO20081045L publication Critical patent/NO20081045L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/285—Arsenic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/72—Aliphatic compounds

Abstract

Foreliggende oppfinnelse tilveiebringer organiske arsen-forbindelser. Mange av disse forbindelser har kraftig in vitro cytotoksisk aktivitet mot en rekke humane tumorcellelinjer, både av faststoff og hematologisk opprinnelse, så vel som mot ondartede blodceller fra pasienter med leukemi.
NO20081045A 2005-07-29 2008-02-28 Forbindelser og fremgangsmater for behandling av cancer NO20081045L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70416305P 2005-07-29 2005-07-29
PCT/US2006/029835 WO2007027344A2 (en) 2005-07-29 2006-07-28 Compounds and methods for the treatment of cancer

Publications (1)

Publication Number Publication Date
NO20081045L true NO20081045L (no) 2008-04-25

Family

ID=37809342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081045A NO20081045L (no) 2005-07-29 2008-02-28 Forbindelser og fremgangsmater for behandling av cancer

Country Status (9)

Country Link
US (3) US7968738B2 (no)
EP (2) EP1919564B1 (no)
JP (1) JP4994374B2 (no)
AU (1) AU2006285329B2 (no)
CA (1) CA2617049A1 (no)
ES (2) ES2532666T3 (no)
HK (2) HK1164767A1 (no)
NO (1) NO20081045L (no)
WO (1) WO2007027344A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1919564B1 (en) 2005-07-29 2014-11-26 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
EP2209480B1 (en) * 2007-11-02 2012-09-05 Ziopharm Oncology, Inc. Combination therapy with organic arsenicals
CN101874034A (zh) * 2007-12-12 2010-10-27 Zio医药肿瘤学公司 用于治疗癌症的化合物和方法
AU2009282972A1 (en) 2008-08-20 2010-02-25 Solasia Pharma K.K. Organoarsenic compounds and methods for the treatment of cancer
EP2897906B1 (en) 2012-09-20 2017-07-05 Bendale, Yogesh Narayan Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancers
KR20160086960A (ko) * 2013-12-05 2016-07-20 솔레이지아 파마 가부시키가이샤 암 치료를 위한 화합물 및 방법
WO2016143746A1 (ja) * 2015-03-12 2016-09-15 一般財団法人化学及血清療法研究所 脱細胞化組織を用いた癒着防止材及び代用生体膜
CN107167433A (zh) * 2016-03-07 2017-09-15 天津国际生物医药联合研究院 一种检测氯二甲基砷的方法
JPWO2019220961A1 (ja) * 2018-05-18 2020-05-28 ソレイジア・ファーマ株式会社 ダリナパルシンのアルカリ金属塩及び／又は無機酸付加塩の結晶型及びその製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277819B1 (en) * 1996-08-30 2001-08-21 Eli Lilly And Company Use of GLP-1 or analogs in treatment of myocardial infarction
ES2309258T3 (es) 1997-10-15 2008-12-16 Polarx Biopharmaceuticals, Inc. Composiciones farmaceuticas que comprenden trioxido de arsenico para el tratamiento de linfoma no hodgkin.
US6770304B2 (en) 1997-11-10 2004-08-03 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
CA2312190A1 (en) * 1997-12-05 1999-06-17 Eli Lilly And Company Glp-1 formulations
CN1233476A (zh) 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
SE9802080D0 (sv) * 1998-06-11 1998-06-11 Hellstroem Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
EP1002537A1 (en) 1998-10-30 2000-05-24 Assistance Publique, Hopitaux De Paris Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma
US6191123B1 (en) 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
DE60118172T2 (de) 2000-04-26 2007-03-08 Oregon Health Sciences University, Portland Verabreichung von einer chemoschützenden verbindung,welche eine thiolgruppe enthält
WO2003057012A2 (en) 2002-01-07 2003-07-17 Board Of Regents, The University Of Texas System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
TW201440760A (zh) * 2004-07-16 2014-11-01 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
EP1919564B1 (en) 2005-07-29 2014-11-26 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
EP2209480B1 (en) * 2007-11-02 2012-09-05 Ziopharm Oncology, Inc. Combination therapy with organic arsenicals

Also Published As

Publication number Publication date
AU2006285329A1 (en) 2007-03-08
HK1164767A1 (en) 2012-09-28
WO2007027344A3 (en) 2007-12-21
CA2617049A1 (en) 2007-03-08
ES2532666T3 (es) 2015-03-30
US20130142730A1 (en) 2013-06-06
ES2531159T3 (es) 2015-03-11
HK1117780A1 (en) 2009-01-23
US8334398B2 (en) 2012-12-18
EP1919564B1 (en) 2014-11-26
AU2006285329A2 (en) 2008-08-14
EP1919564A2 (en) 2008-05-14
AU2006285329B2 (en) 2012-10-04
WO2007027344A2 (en) 2007-03-08
US20070183972A1 (en) 2007-08-09
EP2394702A1 (en) 2011-12-14
US8865764B2 (en) 2014-10-21
US7968738B2 (en) 2011-06-28
EP2394702B1 (en) 2014-12-31
JP4994374B2 (ja) 2012-08-08
US20120022229A1 (en) 2012-01-26
JP2009502971A (ja) 2009-01-29

Similar Documents

Publication Publication Date Title
NO20081045L (no) Forbindelser og fremgangsmater for behandling av cancer
TW200616615A (en) Compounds and methods for the treatment of cancer
WO2006058014A3 (en) Harnessing network biology to improve drug discovery
SG151267A1 (en) Carboline derivatives useful in the inhibition of angiogenesis
NO20075918L (no) Substituerte pyrrolo-pyridiner, forbindelser inneholdende disse, fremgangsmate for deres fremstilling og anvendelse derav
CR20110114A (es) Derivados de picolinamida como inhibidores de cinasa
GB0505781D0 (en) Chemical compounds
WO2005113747A3 (de) Multizelluläre gewebe- und organkultursysteme
NL2000375A1 (nl) Pyrimidinederivaten voor de behandeling van abnormale celgroei.
ATE424159T1 (de) Katheter
UY29826A1 (es) Derivados de pirimidina, sales farmaceuticamente aceptables, esteres de los mismos hidrolisables in vivo, procesos de preparacion y aplicaciones
NZ597075A (en) 1, 2, 4-thiazolidin-3-one derivatives as AMP-activated protein kinase (AMPK) agonists for treating cancer
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
DE602005019762D1 (de) Medizinisches Instrument zum Manipulieren, insbesondere zum Zurückziehen des Gewebes oder des Organes.
GB2467467A (en) Taz/wwtr1 for diagnosis and treatment of cancer
WO2006133361A3 (en) Use of gene expression profiling to predict survival in cancer patient
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
NL1029045A1 (nl) Pyrimidinederivaten voor de behandeling van abnormale celgroei.
TNSN07369A1 (en) Heteroaryl urea derivatives useful for inhibiting chki
WO2007118751A3 (de) Verfahren zur veränderung des atp-adp-verhältnisses in zellen
DE602006007631D1 (de) Verpackung für implantierbare chirurgische Netze.
WO2010028373A3 (en) Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
ATE245655T1 (de) Organische-arsenverbindungen
MY150745A (en) Isoserine derivatives for use as coagulation factor ixa inhibitors
WO2006125815A3 (en) Tetrahydropyridothiophenes for use in the treatment of cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application